Skip to content

The effect and mechanism of dexmedetomidine on perioperative neurocognitive disorder in patients undergoing thoracic surgery

The effect and mechanism of dexmedetomidine on perioperative neurocognitive disorder in patients undergoing thoracic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023596
Enrollment
Unknown
Registered
2019-06-03
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative neurocognitive disorder

Interventions

Dex Group:administrate dexmedetomidine during surgey and patient-controlled analgesia
NS Group:not administrate dexmedetomidine during surgey and patient-controlled analgesia

Sponsors

Chengd Shangjin Nanfu Hospital, West China Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients aged 45 years or older; 2) underwent elective thoracic surgery; 3) with informed consent; 4) with American Society of Anesthesiologists (ASA) class I-III; 5) anesthesia lasted no less than 2 hours.

Exclusion criteria

Exclusion criteria: 1) can not cooperate with the researchers and be unsuitable for the study; 2) with central nervous disease and infection before surgery; 3) the education level under primary school; 4) the Telephone Interview for Cognitive Status-Modified (TICS-m) score less than 28; 5) a history of neurological disease, psychiatric and anti-depression drugs; 6) the inability to communication because of dysaudia and vision disorder; 7) serious hepatic (Child-Pugh class C) and renal dysfunction (undergoing dialysis); 8) sick sinus syndrome, severe sinus bradycardia (<50 beats per min), or second or third degree atrioventricular block without pacemaker.

Design outcomes

Primary

MeasureTime frame
the incidence of postoperative cognitive dysfunction;

Secondary

MeasureTime frame
IL-6;IL-1ß;glial fibrillary acidic portein;pNF-H;

Countries

China

Contacts

Public ContactRurong Wang

Sichuan University Affiliated West China Hospital

rurongwang@foxmai.com+86 18980601563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026